Followers | 16 |
Posts | 1295 |
Boards Moderated | 0 |
Alias Born | 11/15/2007 |
Sunday, March 26, 2017 10:16:13 AM
To protect these achievements, we have built a large portfolio of issued patents and pending patent applications that spans 23 patent families and 53 countries, including over 60 issued patents. The portfolio provides multi-level, extensive coverage of: Pluristem’s cells and pharmaceutical compositions containing them; therapeutic uses (second medical uses) thereof; manufacturing methods; and devices involved in the expansion and harvesting of adherent stromal cells and their subsequent controlled thawing after cryopreservation. Pluristem continues to file new patent applications at a rapid pace, designed to cover the ongoing and dynamic achievements of our Research and Development teams, and to provide exclusive patent rights for many years to come. We believe that this portfolio provides us with a significant commercial advantage in key markets, as we address major therapeutic unmet needs.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM